From: A novel role of HLA class I in the pathology of medulloblastoma
Antibody | Immunohistochemistry scores | Total | |||
---|---|---|---|---|---|
 | 0 | 1 | 2 | 3 |  |
HC-10 | 59 (55.7%) | 33 (31.1%) | 5 (4.7%) | 9 (8.5%) | 106 (100%) |
β2m | 2 (1.6%) | 21 (16.9%) | 28 (22.6%) | 73 (58.9%) | 124 (100%) |
TAP1 | 0 (0.0%) | 11 (8.9%) | 39 (31.5%) | 74 (59.7%) | 124 (100%) |
TAP2 | 16 (13.1%) | 64 (52.5%) | 27 (22.1%) | 15 (12.3%) | 122 (100%) |
CD45 | 60 (58.3%) | 41 (39.8%) | 1 (0.95%) | 1 (0.95%) | 103 (100%) |
CD45* | 6 (42.9%) | 6 (42.9%) | 1 (7.1%) | 1 (7.1%) | 14 (100%) |